Overview

Cholecalciferol on Hemodialysis Patients

Status:
Completed
Trial end date:
2018-09-28
Target enrollment:
Participant gender:
Summary
- Screening the prevalence of vitamin D deficiency among Egyptian hemodialysis patients on a single center (Ain Shams University hospital). - Assessing the effect of the native type of vitamin D (Cholecalciferol) on replenishing its deficiency via extra-renal vitamin D receptors (VDR), among Egyptian hemodialysis patients. - Assessing the effect of cholecalciferol on vascular calcification among Egyptian hemodialysis patients. - Assessing the effect of cholecalciferol on Blood pressure, parathyroid hormone.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Ain Shams University
Treatments:
Cholecalciferol
Ergocalciferols
Vitamin D
Vitamins